SCHEMBL15468643

SCHEMBL15468643

O=NC(=O)CCCCC(CCS)SCc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOLH1 Q04609 2/20 0.38
▸ ACE P12821 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ HDAC3 O15379 2/20 0.33
▸ HDAC4 P56524 2/20 0.33
▸ HDAC1 Q13547 2/20 0.33
▸ HDAC7 Q8WUI4 2/20 0.33
▸ HDAC2 Q92769 2/20 0.33
▸ HDAC10 Q969S8 2/20 0.33
▸ HDAC11 Q96DB2 2/20 0.33
▸ HDAC8 Q9BY41 2/20 0.33
▸ HDAC6 Q9UBN7 2/20 0.33
▸ HDAC9 Q9UKV0 2/20 0.33
▸ HDAC5 Q9UQL6 2/20 0.33
▸ PPARG P37231 1/20 0.33
▸ PPARA Q07869 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ ATM Q13315 1/20 0.32
▸ L3MBTL1 Q9Y468 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10307799 0.86 MAPT (0.46) FOLH1CYP2C19HDAC3HDAC4HDAC1
SCHEMBL14027320 0.84 ALDH1A1 (0.42) FOLH1CYP2C19PPARGPPARAATM
SCHEMBL15468646 0.78 CYSLTR2 (0.38) CYP2C19HDAC3HDAC4HDAC1HDAC7
SCHEMBL15468633 0.77 GSTK1 (0.32) —
SCHEMBL15468649 0.76 CYP2C19 (0.39) CYP2C19MAPTSMN1; SMN2
Cpi 613 SCHEMBL1062218 0.71 CYP2C19 (0.59) FOLH1CYP2C19HDAC3HDAC4HDAC1
Cpi 613 SCHEMBL13333201 0.71 CYP2C19 (0.59) FOLH1CYP2C19HDAC3HDAC4HDAC1
SCHEMBL3713575 0.71 MAPT (0.47) CYP2C19HDAC3HDAC4HDAC1HDAC7
SCHEMBL22299081 0.70 CYP2C19 (0.58) FOLH1CYP2C19HDAC3HDAC4HDAC1
SCHEMBL10454113 0.70 CYP2C19 (0.46) FOLH1CYP2C19HDAC3HDAC4HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2695614-A1 Lipoic acid derivatives Cornerstone Pharmaceuticals, Inc. (US) 2014-02-12 — — EP disclosed
Send feedback